Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

Gaspar, 2011, Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction., Sci Transl Med, 3, 97ra80, 10.1126/scitranslmed.3002716

Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia., Sci Transl Med, 3, 95ra73, 10.1126/scitranslmed.3002842

Porter, 2011, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia., N Engl J Med, 365, 725, 10.1056/NEJMoa1103849

Hacein-Bey-Abina, 2010, Efficacy of gene therapy for X-linked severe combined immunodeficiency., N Engl J Med, 363, 355, 10.1056/NEJMoa1000164

Rama, 2010, Limbal stem-cell therapy and long-term corneal regeneration., N Engl J Med, 363, 147, 10.1056/NEJMoa0905955

Petersdorf, 2001, Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation., N Engl J Med, 345, 1794, 10.1056/NEJMoa011826

Opelz, 1999, HLA compatibility and organ transplant survival. Collaborative Transplant Study., Rev Immunogenet, 1, 334

Früh, 1997, Inhibition of MHC class I antigen presentation by viral proteins., J Mol Med (Berl), 75, 18, 10.1007/s001090050082

Berger, 2000, Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes., J Virol, 74, 4465, 10.1128/JVI.74.10.4465-4473.2000

Riolobos

Figueiredo, 2006, Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery., J Mol Med (Berl), 84, 425, 10.1007/s00109-005-0024-2

Gonzalez, 2005, Amplification of RNAi—targeting HLA mRNAs., Mol Ther, 11, 811, 10.1016/j.ymthe.2004.12.023

Haga, 2006, Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes., Transplant Proc, 38, 3184, 10.1016/j.transproceed.2006.10.158

Sykulev, 1996, Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response., Immunity, 4, 565, 10.1016/S1074-7613(00)80483-5

Urnov, 2010, Genome editing with engineered zinc finger nucleases., Nat Rev Genet, 11, 636, 10.1038/nrg2842

Perez, 2008, Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases., Nat Biotechnol, 26, 808, 10.1038/nbt1410

O’Connor, 2012, Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy., Sci Rep, 2, 249, 10.1038/srep00249

Manuri, 2010, piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies., Hum Gene Ther, 21, 427, 10.1089/hum.2009.114

Singh, 2008, Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system., Cancer Res, 68, 2961, 10.1158/0008-5472.CAN-07-5600

Torikai, 2012, A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR., Blood, 119, 5697, 10.1182/blood-2012-01-405365

Doyon, 2010, Transient cold shock enhances zinc-finger nuclease-mediated gene disruption., Nat Methods, 7, 459, 10.1038/nmeth.1456

Guschin, 2010, A rapid and general assay for monitoring endogenous gene modification., Methods Mol Biol, 649, 247, 10.1007/978-1-60761-753-2_15

Lengner, 2010, Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations., Cell, 141, 872, 10.1016/j.cell.2010.04.010

Soldner, 2009, Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors., Cell, 136, 964, 10.1016/j.cell.2009.02.013

Hockemeyer, 2008, A drug-inducible system for direct reprogramming of human somatic cells to pluripotency., Cell Stem Cell, 3, 346, 10.1016/j.stem.2008.08.014

Johnson, 2003, Locus-specific constitutive and cytokine-induced HLA class I gene expression., J Immunol, 170, 1894, 10.4049/jimmunol.170.4.1894

Mori, 1997, HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry., Transplantation, 64, 1017, 10.1097/00007890-199710150-00014

Miller, 2007, An improved zinc-finger nuclease architecture for highly specific genome editing., Nat Biotechnol, 25, 778, 10.1038/nbt1319

Jena, 2010, Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor., Blood, 116, 1035, 10.1182/blood-2010-01-043737

Kebriaei, 2012, Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies., Hum Gene Ther, 23, 444, 10.1089/hum.2011.167

Kochenderfer, 2012, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells., Blood, 119, 2709, 10.1182/blood-2011-10-384388

Brentjens, 2011, Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias., Blood, 118, 4817, 10.1182/blood-2011-04-348540

Kochenderfer, 2010, Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19., Blood, 116, 4099, 10.1182/blood-2010-04-281931

Provasi, 2012, Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer., Nat Med, 18, 807, 10.1038/nm.2700

Singh, 2011, Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies., Cancer Res, 71, 3516, 10.1158/0008-5472.CAN-10-3843

Drukker, 2002, Characterization of the expression of MHC proteins in human embryonic stem cells., Proc Natl Acad Sci USA, 99, 9864, 10.1073/pnas.142298299

Brower, 1994, Minimal requirements for peptide mediated activation of CD8+ CTL., Mol Immunol, 31, 1285, 10.1016/0161-5890(94)90079-5

Felix, 2007, Specificity of T-cell alloreactivity., Nat Rev Immunol, 7, 942, 10.1038/nri2200

Cooper, 2012, Good T cells for bad B cells., Blood, 119, 2700, 10.1182/blood-2011-12-398719

Liu, 2010, Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases., Biotechnol Bioeng, 106, 97, 10.1002/bit.22654

Zhao, 2011, Immunogenicity of induced pluripotent stem cells., Nature, 474, 212, 10.1038/nature10135

Katagiri, 2011, Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia., Blood, 118, 6601, 10.1182/blood-2011-07-365189

Parham, 2005, MHC class I molecules and KIRs in human history, health and survival., Nat Rev Immunol, 5, 201, 10.1038/nri1570

Borrego, 1998, Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis., J Exp Med, 187, 813, 10.1084/jem.187.5.813

Braud, 1998, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C., Nature, 391, 795, 10.1038/35869

Riteau, 2001, HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition., Int Immunol, 13, 193, 10.1093/intimm/13.2.193

Rouas-Freiss, 1997, The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?, Proc Natl Acad Sci USA, 94, 5249, 10.1073/pnas.94.10.5249

Brickner, 2006, The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL., Blood, 107, 3779, 10.1182/blood-2005-08-3501

Tykodi, 2008, C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients., Clin Cancer Res, 14, 5260, 10.1158/1078-0432.CCR-08-0028